标题
Emerging Concepts and Technologies in Vaccine Development
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-09-30
DOI
10.3389/fimmu.2020.583077
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?
- (2020) E. Andrew Townsend et al. CNS DRUGS
- COVID‐19 vaccines: knowing the unknown
- (2020) Huibin Lv et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Ensuring global access to COVID-19 vaccines
- (2020) Gavin Yamey et al. LANCET
- Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees
- (2020) Shibo Jiang NATURE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
- (2020) Linling He et al. Science Advances
- Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
- (2020) Christian F. Singer et al. EUROPEAN JOURNAL OF CANCER
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- COVID-19 vaccines for all?
- (2020) Ann Danaiya Usher LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Covid-19: Where are we on immunity and vaccines?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Covid-19: Russia approves vaccine without large scale testing or published results
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
- (2019) Karim Vermaelen Frontiers in Immunology
- Nanoparticle systems for cancer vaccine
- (2019) Ru Wen et al. Nanomedicine
- Factors That Influence the Immune Response to Vaccination
- (2019) Petra Zimmermann et al. CLINICAL MICROBIOLOGY REVIEWS
- Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility
- (2019) Nicholas C. Wu et al. Cell Host & Microbe
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Rational design of Zika virus subunit vaccine with enhanced efficacy
- (2019) Wanbo Tai et al. JOURNAL OF VIROLOGY
- Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
- (2019) Beatris Mastelic-Gavillet et al. Frontiers in Immunology
- The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms
- (2019) Yicheng Yang et al. Frontiers in Microbiology
- Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention
- (2019) Anna Aiello et al. Frontiers in Immunology
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination
- (2018) Satoshi Uchida et al. BIOMATERIALS
- Virus-like antigen display for cancer vaccine development, what is the potential?
- (2018) Adam F. Sander et al. Expert Review of Vaccines
- Single-cycle adenovirus vectors in the current vaccine landscape
- (2018) Michael Barry Expert Review of Vaccines
- Toward rational antibody design: recent advancements in molecular dynamics simulations
- (2018) Takefumi Yamashita INTERNATIONAL IMMUNOLOGY
- Novel Vaccine Technologies
- (2018) Barney S. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer
- (2018) Y.S. Tan et al. JOURNAL OF DENTAL RESEARCH
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- (2018) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
- (2018) Annette B. Vogel et al. MOLECULAR THERAPY
- mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
- (2018) Yuhua Wang et al. MOLECULAR THERAPY
- Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer
- (2018) Eva Zupančič et al. Nanomedicine-Nanotechnology Biology and Medicine
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
- (2018) César López-Camacho et al. Nature Communications
- Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment
- (2018) David L. Elion et al. Oncotarget
- Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
- (2018) Jinyu Han et al. Polymers
- Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids
- (2018) Pavlos C. Englezou et al. Molecular Therapy-Nucleic Acids
- Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine
- (2018) Mei-Le Keck et al. Frontiers in Immunology
- Virus-like particle display of HER2 induces potent anti-cancer responses
- (2018) Arianna Palladini et al. OncoImmunology
- Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
- (2018) Elias Sayour et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture
- (2018) Zoltán Kis et al. Biotechnology Journal
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protein-based nanoparticles in cancer vaccine development
- (2018) Medea Neek et al. Nanomedicine-Nanotechnology Biology and Medicine
- Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
- (2018) Zhihai Li et al. Nature Communications
- Nanoparticle Vaccines Against Infectious Diseases
- (2018) Rashmirekha Pati et al. Frontiers in Immunology
- Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response
- (2017) Atefeh Arab et al. IMMUNOLOGIC RESEARCH
- Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming
- (2017) Eva Zupančič et al. JOURNAL OF CONTROLLED RELEASE
- A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse
- (2017) Agnieszka Sulima et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Clinically Viable Heroin Vaccine
- (2017) Paul T. Bremer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Pertussis and influenza immunisation during pregnancy: a landscape review
- (2017) Bahaa Abu Raya et al. LANCET INFECTIOUS DISEASES
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
- (2017) Christiane R Stadler et al. NATURE MEDICINE
- Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats
- (2017) Jacques D. Nguyen et al. NEUROPHARMACOLOGY
- Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger
- (2017) Sheila Isanaka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conjugate Vaccine Immunotherapy for Substance Use Disorder
- (2017) Paul T. Bremer et al. PHARMACOLOGICAL REVIEWS
- Tumour virus vaccines: hepatitis B virus and human papillomavirus
- (2017) Margaret Stanley PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Policy making for vaccine use as a driver of vaccine innovation and development in the developed world
- (2017) Katherine Seib et al. VACCINE
- Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
- (2017) Sarah C. Gilbert et al. VACCINE
- Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy
- (2017) Hanmei Li et al. Theranostics
- Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
- (2017) Margaret E. Gatti-Mays et al. Human Vaccines & Immunotherapeutics
- Vaccines for epidemic infections and the role of CEPI
- (2017) Stanley A. Plotkin Human Vaccines & Immunotherapeutics
- Zika virus-like particle (VLP) based vaccine
- (2017) Hélène Boigard et al. PLoS Neglected Tropical Diseases
- Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
- (2017) Eleni Maria Varypataki et al. Cancer Immunology Research
- Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design
- (2017) Edison Ong et al. Frontiers in Immunology
- DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
- (2017) Sarah T. C. Elliott et al. npj Vaccines
- Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial
- (2017) G. Haidari et al. Scientific Reports
- An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life
- (2016) Atsushi Kimishima et al. ACS Chemical Biology
- Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs
- (2016) Paul T. Bremer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Vaccine technologies: From whole organisms to rationally designed protein assemblies
- (2016) Christopher P. Karch et al. BIOCHEMICAL PHARMACOLOGY
- Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
- (2016) N. J. Mason et al. CLINICAL CANCER RESEARCH
- Optimization of a methamphetamine conjugate vaccine for antibody production in mice
- (2016) Misty W. Stevens et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
- (2016) Rino Rappuoli et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Methamphetamine Vaccines: Improvement through Hapten Design
- (2016) Karen C. Collins et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Post isolation modification of exosomes for nanomedicine applications
- (2016) Joshua L Hood Nanomedicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains
- (2016) Richard C. Condit et al. VACCINE
- Universal influenza vaccines: Shifting to better vaccines
- (2016) Francesco Berlanda Scorza et al. VACCINE
- Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
- (2016) Lukasz Bialkowski et al. Scientific Reports
- Evolution of rational vaccine designs for genital herpes immunotherapy
- (2016) Johanna Katharina Kaufmann et al. Current Opinion in Virology
- Selection of HIV vaccine candidates for concurrent testing in an efficacy trial
- (2016) Ying Huang et al. Current Opinion in Virology
- Engineering virus-like particles as vaccine platforms
- (2016) Kathryn M Frietze et al. Current Opinion in Virology
- Biologics to treat substance use disorders: Current status and new directions
- (2016) Marco Pravetoni Human Vaccines & Immunotherapeutics
- Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform
- (2016) Josef Singer et al. OncoImmunology
- Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
- (2016) Elias J. Sayour et al. OncoImmunology
- Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
- (2016) George M. Warimwe et al. Scientific Reports
- Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
- (2016) Niels Peter H. Knudsen et al. Scientific Reports
- The aged lymphoid tissue environment fails to support naïve T cell homeostasis
- (2016) Bryan R. Becklund et al. Scientific Reports
- Efficacy, but Not Antibody Titer or Affinity, of a Heroin Hapten Conjugate Vaccine Correlates with Increasing Hapten Densities on Tetanus Toxoid, but Not on CRM197 Carriers
- (2015) Rashmi Jalah et al. BIOCONJUGATE CHEMISTRY
- CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
- (2015) Rodney A. Rosalia et al. BIOMATERIALS
- Anti-nicotine vaccines: Comparison of adjuvanted CRM 197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates
- (2015) Michael J. McCluskie et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates
- (2015) Michael J. McCluskie et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics
- (2015) Cornelia Lorenzer et al. JOURNAL OF CONTROLLED RELEASE
- Paradoxical changes in innate immunity in aging: recent progress and new directions
- (2015) Ruth R. Montgomery et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose
- (2015) Rekha Dhanwani et al. JOURNAL OF VIROLOGY
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- (2015) P. H. Lizotte et al. Nature Nanotechnology
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer
- (2015) V. Riabov et al. VACCINE
- Computational tools for epitope vaccine design and evaluation
- (2015) Linling He et al. Current Opinion in Virology
- Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production
- (2015) Patricio Oyarzún et al. Human Vaccines & Immunotherapeutics
- RNA-Based Vaccines in Cancer Immunotherapy
- (2015) Megan A. McNamara et al. Journal of Immunology Research
- Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens
- (2015) Lassi Liljeroos et al. Journal of Immunology Research
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- Investigating Hapten Clustering as a Strategy to Enhance Vaccines against Drugs of Abuse
- (2014) Karen C. Collins et al. BIOCONJUGATE CHEMISTRY
- Innate immunesenescence: underlying mechanisms and clinical relevance
- (2014) Jon Hazeldine et al. BIOGERONTOLOGY
- Vaccine for cocaine dependence: A randomized double-blind placebo-controlled efficacy trial
- (2014) Thomas R. Kosten et al. DRUG AND ALCOHOL DEPENDENCE
- mRNA-based dendritic cell vaccines
- (2014) Daphné Benteyn et al. Expert Review of Vaccines
- Aging and Cytomegalovirus Infection Differentially and Jointly Affect Distinct Circulating T Cell Subsets in Humans
- (2014) A. M. Wertheimer et al. JOURNAL OF IMMUNOLOGY
- Defective Interfering Influenza Virus RNAs: Time To Reevaluate Their Clinical Potential as Broad-Spectrum Antivirals?
- (2014) N. J. Dimmock et al. JOURNAL OF VIROLOGY
- Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats
- (2014) Marco Pravetoni et al. PLoS One
- Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats
- (2014) Marco Pravetoni et al. PLoS One
- History of vaccination
- (2014) S. Plotkin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
- (2014) Jaap T. van Dissel et al. VACCINE
- Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
- (2014) Kyle K. L. Phua et al. Scientific Reports
- Antigen-specific vaccines for cancer treatment
- (2014) Maria Tagliamonte et al. Human Vaccines & Immunotherapeutics
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Protection and Antibody Response Caused by Turkey Herpesvirus Vector Newcastle Disease Vaccine
- (2013) Motoyuki Esaki et al. AVIAN DISEASES
- Structural Vaccinology: A Three-dimensional View for Vaccine Development
- (2013) Ilaria Ferlenghi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Therapeutic vaccines against tobacco addiction
- (2013) Raafat EF Fahim et al. Expert Review of Vaccines
- Turning Tumors into Vaccines: Co-opting the Innate Immune System
- (2013) Jasper G. van den Boorn et al. IMMUNITY
- Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)
- (2013) Eun-Ae Cho et al. LANCET
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice
- (2013) David C. Pryde et al. PLoS One
- Immunogenicity of Individual Vaccine Components in a Bivalent Nicotine Vaccine Differ According to Vaccine Formulation and Administration Conditions
- (2013) Katherine E. Cornish et al. PLoS One
- Dynamic vaccine blocks relapse to compulsive intake of heroin
- (2013) J. E. Schlosburg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Challenges and advances towards the rational design of mRNA vaccines
- (2013) Charlotte Pollard et al. TRENDS IN MOLECULAR MEDICINE
- Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food
- (2013) Daniela Rüedi-Bettschen et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Rational Epitope Design for Protein Targeting
- (2012) Claudio Peri et al. ACS Chemical Biology
- Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir
- (2012) Nigel J. Dimmock et al. ANTIVIRAL RESEARCH
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
- (2012) Tobias R. Kollmann et al. IMMUNITY
- Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence
- (2012) Melissa B. Uccellini et al. IMMUNOLOGY LETTERS
- The future of human DNA vaccines
- (2012) Lei Li et al. JOURNAL OF BIOTECHNOLOGY
- Reduced Antinociception of Opioids in Rats and Mice by Vaccination with Immunogens Containing Oxycodone and Hydrocodone Haptens
- (2012) Marco Pravetoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
- (2012) Charles Lu et al. PLoS One
- Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established
- (2012) Nigel J. Dimmock et al. PLoS One
- Changes in primary lymphoid organs with aging
- (2012) Ivan K. Chinn et al. SEMINARS IN IMMUNOLOGY
- B cell maintenance and function in aging
- (2012) Igor Kogut et al. SEMINARS IN IMMUNOLOGY
- Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine
- (2012) D. Jas et al. VACCINE
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Vaccines: From Empirical Development to Rational Design
- (2012) Christine Rueckert et al. PLoS Pathogens
- Immunogenicity and Smoking-Cessation Outcomes for a Novel Nicotine Immunotherapeutic
- (2011) D K Hatsukami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Review of diphtheria, tetanus and pertussis vaccines in clinical development
- (2011) Nicholas RE Kitchin Expert Review of Vaccines
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway
- (2011) Stephanie J Win et al. IMMUNOLOGY AND CELL BIOLOGY
- CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells
- (2011) David Franco et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus
- (2011) P. D. Scott et al. JOURNAL OF GENERAL VIROLOGY
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- A Vaccine Strategy that Induces Protective Immunity against Heroin
- (2011) G. Neil Stowe et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Distinct Chemical Structures for the Development of a Methamphetamine Vaccine
- (2011) Amira Y. Moreno et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
- (2011) Ally Olotu et al. LANCET INFECTIOUS DISEASES
- Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles
- (2011) Seyed Amir Jalali et al. Nanomedicine-Nanotechnology Biology and Medicine
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo
- (2011) Paul D. Scott et al. VACCINE
- A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo
- (2011) Andrew J. Easton et al. VACCINE
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice
- (2011) Hongli Zhou et al. Virology Journal
- Defective interfering virus protects elderly mice from influenza
- (2011) Paul D Scott et al. Virology Journal
- Toll-Like Receptor Agonists
- (2010) Sacha Gnjatic et al. CANCER JOURNAL
- Ageing is associated with diminished apoptotic cell clearance in vivo
- (2010) T. Aprahamian et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
- (2010) Malou Henriksen-Lacey et al. JOURNAL OF CONTROLLED RELEASE
- TLR-Activated Dendritic Cells Enhance the Response of Aged Naive CD4 T Cells via an IL-6-Dependent Mechanism
- (2010) S. C. Jones et al. JOURNAL OF IMMUNOLOGY
- Leukocyte function in the aging immune system
- (2010) Anjali Desai et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
- (2010) Agnes E. Coutinho et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A Critical Evaluation of a Nicotine Vaccine within a Self-Administration Behavioral Model
- (2010) Amira Y. Moreno et al. MOLECULAR PHARMACEUTICS
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained Patients
- (2009) Bridget A. Martell et al. ARCHIVES OF GENERAL PSYCHIATRY
- A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
- (2009) Ursula Wiedermann et al. BREAST CANCER RESEARCH AND TREATMENT
- TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program
- (2009) S. Chamorro et al. JOURNAL OF IMMUNOLOGY
- Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients
- (2009) C. Luther et al. JOURNAL OF IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
- IC31®, a Two-Component Novel Adjuvant Mixed with a Conjugate Vaccine Enhances Protective Immunity against Pneumococcal Disease in Neonatal Mice
- (2009) T. A. Olafsdottir et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease
- (2009) L. El-Attar et al. VACCINE
- Murine pneumotropic virus chimeric Her2/neuvirus-like particles as prophylactic and therapeutic vaccines against Her2/neuexpressing tumors
- (2008) Kalle Andreasson et al. INTERNATIONAL JOURNAL OF CANCER
- Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral
- (2008) N. J. Dimmock et al. JOURNAL OF VIROLOGY
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
- (2008) Philip Bejon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial
- (2008) Jacques Cornuz et al. PLoS One
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started